Five lessons from the healthcare supply chain’s response to COVID-19
The COVID-19 pandemic has tested the resiliency of the healthcare supply chain. At AmerisourceBergen, we have long recognized that partnerships, data, efficiency, and sheer human spirit are vital components to ensuring supply chain stability and meeting our customers’ needs.
Be prepared for anything
Data enables innovation
Partnerships are key to success
- Customers along the healthcare supply chain rely on the products and services distributors provide. It’s crucial that any disruptions to operations cannot impact our ability to deliver. AmerisourceBergen communicates regularly with our customers and manufacturer partners on how we have evolved to meet needs during this unpredictable time.
- We continue to develop and deepen relationships with manufacturers, non-profits, and governments to enable faster distribution and a more durable supply chain. Public-private partnerships with the United States federal government, FDA, FEMA, HHS, and state governments have been crucial to meet shifting demands.
- Our partnership with Healthcare Ready allows us to support the Essential Medicines Strategic Stockpile Act of 2020, which disseminates pharmaceuticals to high-infection areas in the United States.
- Globally, the AmerisourceBergen family of companies has built strong partnerships in the fight against COVID-19. Innomar Strategies is partnering with the Canadian government to provide specialized cold-chain packaging and vaccine distribution capabilities. World Courier is working with multiple international governments to support the business continuity of the biopharma supply chain.
Pharmaceuticals are efficient and effective
- The delivery and use of pharmaceuticals continue to be the most efficient form of healthcare.
- Our distribution model enables turnkey pharmaceutical access and allows AmerisourceBergen to be an effective and efficient partner to tens of thousands of community providers nationwide.
- As the FDA issued Emergency Use Authorizations (EUA) for Veklury (remdesivir) and monoclonal antibodies and other COVID-19 therapies, AmerisourceBergen partnered with the United States government and manufacturers to facilitate the swift movement of those therapies to sites of care.
- Good Neighbor Pharmacy and Elevate Provider Network are participating in the Federal Retail Pharmacy Program to distribute vaccines to their local communities across the United States. This will enable people living in some of the most rural communities to have access to COVID-19 vaccines.
The human spirt is resilient
“It's been very humbling for me to see the empathy and the support from our entire company. There's this continual focus on asking, How can we be better? How can we treat more patients? How can we live the purpose of AmerisourceBergen? There are days where we get personal outreach from patients as a thank you. And they'll say, 'It was my grandfather, or my niece, or my nephew, or my wife, or myself, who received this therapy.' It's very touching and powerful to be a part of that."
- Heather Zenk, RPh, PharmD, Senior Vice President, Strategic Global Sourcing